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Multisystemic therapy is a manualised treatment programme for young people who exhibit 
antisocial behaviour. The Systemic Therapy for At Risk Teens trial is the first large-scale 
randomised controlled trial of multisystemic therapy in the UK. Previous findings reported to 
18 months post-baseline did not indicate superiority of multisystemic therapy compared with 
management as usual. Here, we report outcomes of the trial to 60 months. 
Methods 
Young people aged 11–17 years with moderate-to-severe antisocial behaviour were randomly 
allocated to management as usual (n=342) or 3–5 months of multisystemic therapy followed 
by management as usual (n=342). The primary outcome was proportion of offences with 
convictions in the groups. 
Findings 
By 60 months’ follow-up, 55% of the multisystemic therapy group had at least one offence 
with a criminal conviction, compared with 53% of the management-as-usual group (odds 
ratio 1·13, 95% CI: 0·82, 1·56; p=0·44). 
Interpretation 
The results of the 5-year follow-up show no evidence of longer-term superiority for 
multisystemic therapy compared with management as usual. 
Funding 




Antisocial behaviour is a key component of conduct disorder, a clinical syndrome that can 
have significant personal, interpersonal and societal costs.1 Young people with conduct 
disorder are at risk of developing persistent long-term psychological and behavioural 
problems.2 There were an estimated 1,240,000 cases of conduct disorder in England in 20143. 
The lifetime savings associated with preventing conduct disorder by early intervention are 
estimated to be £260,000 per severe case.4  The burden of antisocial behaviour is long-term 
for both young people and the communities in which they live; thus, it is essential to 
understand the long-term efficacy of interventions in order to appraise their value beyond 
limiting the strain on current services.  
Multisystemic therapy (MST) was initially designed in the USA as an intervention for 
families with young people who engage in antisocial behaviour and are at risk of becoming 
young offenders. It is an intensive, family-focused programme that helps young people 
manage their behaviour in various contexts, including at home, at school, and in the 
community.5 High-quality, quantitative systematic reviews showed that MST helps to reduce 
adolescent antisocial and offending behaviour and improves individual and family problems, 
but the majority of studies with positive results are from the USA, and replications in other 
countries have had mixed outcomes6. All longer-term follow-up studies are based on US 
samples and carried out by the developers of the treatment; these typically report short 
follow-up periods for secondary outcomes other than criminal behaviour.7,8 In essence, the 
longer-term outcomes of MST are not known.  
The Systemic Therapy for At Risk Teens (START) trial was a pragmatic randomised 
controlled trial evaluating the effectiveness of MST, implemented to international treatment 
fidelity standards, compared with management as usual (MAU) at nine pilot sites across 
England. MAU involved standard local care offered by a range of services, including mental 
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health, juvenile justice, social care and education, in varying combinations across settings. 
Overall, 684 families took part in the trial, with 50% (n=342) assigned to MST and 50% 
(n=342) assigned to MAU. Full demographic characteristics at baseline are shown in Table 1.  
The outcomes of the START trial to 18 months were mixed.9 The primary outcome selected 
by commissioners of the trial was the proportion of out-of-home placement because of its 
association with high costs and poor long-term outcomes for young people. The results 
indicated that out-of-home placements were infrequent (approximately 20%) in both groups, 
with no significant difference between the two groups. Similarly, although offending 
decreased over time in both groups, there was no evidence to suggest that MST was superior 
to MAU in reducing criminal behaviour, and the mean number of recorded offences was 
slightly higher in the MST group than the MAU group at 18 months. Secondary outcomes 
were more promising, consistently suggesting that parents in the MST group perceived 
greater improvements to young people’s antisocial behaviour compared with those in the 
MAU group. Parents also saw improvements in the young people’s mental health, mood, and 
family functioning, and reported positive changes to their own parenting strategies. These 
findings, however, were not sustained at 18 months, and the overall results of the trial did not 
show any clear evidence of superiority of MST over MAU. 
The purpose of this follow-up study is to evaluate the medium- to long-term effectiveness of 
MST compared with MAU.  The follow-up period was 60 months for the primary outcome 
(the proportion of young people with any criminal conviction) and 48 months for secondary 
outcomes (psychiatric problems and areas in which conduct disorder is likely to result in 
poorer outcomes, including educational and work attainment, social relationships, pregnancy 




Study design and participants 
The START study was a pragmatic trial to determine the superiority of brief MST followed 
by MAU compared with MAU alone in addressing antisocial behaviour in young people. The 
study design and procedures are fully described in the published trial protocol 
(https://www.isrctn.com/ISRCTN77132214) and results up to 18 months have been reported.9 
The study protocol was approved by the London South-East Research Ethics Committee for 
data collection to 18 months (09/H1102/55) and extended data collection to 60 months 
(09/H1102/55). All participants met at least one of the following indicators of antisocial 
behaviour (violent and aggressive behaviour; at least one conviction plus three additional 
warnings, reprimands, or convictions; diagnosis of treatment-resistant conduct disorder; 
school exclusion; risk of harm) across several settings and minimal exclusion criteria 
(appendix p.1). 
Randomisation and masking 
The investigators and objective assessors used a secure randomisation protocol and were 
strictly masked to treatment allocation. Masking was maintained throughout the follow-up 
period, with clinical and research staff located separately to avoid leakage of information. All 
coding, data entry and data cleaning were done by individuals masked to allocation. Data 
were warehoused separately from the research teams. A random sample (25%) of data was 
double-entered to check for entry errors. Allocation data were kept physically inaccessible to 
investigators and research assistants. The evaluation of treatment fidelity (see below) was 




MST10 is an intensive family- and home-based intervention for young people with serious 
antisocial behaviour. The MST therapist worked with the young person’s family to improve 
parenting, enhance relationships, garner support from social networks, address 
communication problems, encourage adaptive behaviour (eg, school attendance) and reduce 
maladaptive habits (eg, association with delinquent peers). Therapists saw only a few families 
at a time. Therapists saw each family three times a week for 3–5 months, and were available 
for crisis calls 24 h a day, 7 days a week. Programme fidelity was maintained by expert 
supervision and the use of a well-developed quality assurance system implemented at each 
clinical site (details can be found in the appendix to the first START paper9). The Therapist 
Adherence Measure-Revised (TAM-R), based on interviews conducted with the parents or 
carers as the treatment was in progress, indicated that therapists at all sites delivered MST 
that was adherent to the criteria specified by the treatment developers.9 Following MST, 
families received MAU (described below). 
MAU was based on the best available local services for each young person, in line with 
current community practice informed by treatment guidelines, and was offered on an as-
needed basis (eg, support to re-engage with education, anger management, or victim 
awareness programmes) without formulation, an overarching plan, standardisation or 
supervision. The MAU interventions were supported by Youth Offending Teams (YOTs), 
Child and Adolescent Mental Health Services (CAMHS), and social and education services 
(see appendix p.7 for details).  
Outcomes 
The primary outcome was the proportion of young people who are known to have committed 
one or more criminal offence that led to a conviction in each arm of the trial at 60 months 
post-randomisation. To ensure comparability with other trials of MST, the total number of 
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recorded offences was taken as the outcome variable, based on official records from the 
Police National Computer and Young Offender Information System (a centralised database 
that records all offending within the UK, including date and type of offence, whether the 
offence resulted in a conviction (as not all offences do), and whether the conviction resulted 
in a custodial sentence, community sentence, or a caution). Offending data were collected 
over the course of the trial from 8th August 2011 to 4th September 2017. For the purposes of 
the analyses, offences were categorised as violent, non-violent, or breach of probation. Time 
to first offence was based on the date of the first recorded offence. 
We also report a wide range of secondary outcomes prespecified in our research protocol 
consistent with the ecological focus of MST in addressing youth antisocial behaviour with its 
impact on criminality, education, and mental health. All outcomes were initially assessed at 
baseline and at 6, 12, and 18 months after randomisation. For the current follow-up period, 
secondary measures were collected at 24, 36, and 48 months post-baseline, and primary 
measures were collected up to 60 months. Families were sent an opt-out letter inviting them 
to decide whether they wanted to continue taking part in the trial. Families that did not opt 
out were contacted to confirm whether they wished to participate, to explain to them what 
participation would entail, and to ask them to complete a new consent form. Data collection 
was overseen by an independently chaired Trial Steering Committee and a Data Monitoring 
and Ethics Committee. 
Secondary outcomes were self-report measures, completed by the young person and their 
parent or carer with the assistance of a research assistant, typically within the family home. 
The questionnaire pack took approximately 2 hours to complete, and families received £25 in 
remuneration. Questionnaires were collected between 8th August 2011 and 4th September 
2016. (For brief descriptions and associated hypotheses see the appendix pp.8-12). 
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Self-reported outcomes collected from baseline included measures of antisocial behaviour 
and attitudes that were targets of MST, completed by either the young person (Y) or the 
parent (A) or both (YA) (Strengths and Difficulties Questionnaire [SDQ-YA],11 Inventory of 
Callous-Unemotional Traits [ICU-YA],12 Self-Report Delinquency Measure [SRD-Y],13 
Antisocial Beliefs and Attitudes Scale [ABAS-Y],14 Youth/Adult Materialism Scale [YMS-
Y],15 and the ADHD and Learning & Language subscales of the Conners Comprehensive 
Behaviour Rating Scales [CBRS-Y]16). Some adult-specific measures were used from 24-
month follow-up for participants who turned 18 during this period. These included the Adult 
Behaviour Checklist (ABC-Y),17 the SDQ for Siblings, and the Adult Self Report (ASR-Y).17 
Intermediate outcome measures of parenting skills and family functioning, which are 
assumed by the developers to account for treatment effects, included the Alabama Parenting 
Questionnaire (APQ-YA),18 the Loeber Caregiver Questionnaire (LCQ-A),19 the Family 
Adaptability and Cohesion Evaluation Scale (FACES-IV-A),20 the Level of Expressed 
Emotion Questionnaire (LEE-Y),21 and the Conflict Tactics Scale (CTS2-A).22 As antisocial 
behaviour impacts on parental wellbeing, questionnaire measures concerning parental and 
young people’s wellbeing and adjustment included the Short Mood and Feelings 
Questionnaire (SMFQ-Y),23 the SDQ, and the General Health Questionnaire (GHQ-A).24 
Some measures were administered only from 24-month follow-up. These included the SF-
3625 (a quality of life measure), the Coddington Life Events Scale (CLES-A),26 and the 
Adolescent Resilience Questionnaire (ARQ-Y).27 
Economic outcomes included the use of health, social care, education, and criminal justice 
sector services. The Child and Adolescent-Service Use Schedule, designed specifically for 
the trial, enabled us to monitor service use. Young people’s quality of life was assessed using 
the EQ-5D-3L.28  
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The outcome measures administered and their schedule are provided in the appendix. 
Changes to trial outcomes include the lack of data from the National Pupil Database, as it was 
not possible to reliably link the data to trial follow-up points. A characterisation of MST 
services was also planned during this follow-up period, including characteristics of the 
service, team operations, and the range of interventions available. Unfortunately, it was not 
possible to do this due to services being discontinued.   
Statistical analysis 
All analyses, except where noted, were prespecified in a statistical analysis plan agreed with 
the data monitoring committee. 
The primary outcome was analysed using a mixed-effects logistic regression model with a 
fixed effect for treatment arm allocation. The model was adjusted for number of criminal 
offences which led to a conviction before randomisation, sex, age at onset of criminal 
behaviour (early or late) as fixed effects, and site as a random effect. The model was fitted in 
R using the library lme4. 
The primary analysis estimated the odds ratio between MAU and MST, with confidence 
interval and p-value. 
The time-to-event outcome (time to first offence) was analysed using a Cox proportional 
hazards model adjusted for the same fixed effects as the primary outcome. Count data 
outcomes (number and types of delinquent acts) were analysed using Poisson mixed models. 
The continuous outcomes (all questionnaire outcomes) were analysed with linear mixed 
effects. All models included covariates from the primary outcome model as well as the 
respective baseline measure. 
All analyses were performed with statistical methods that handle outcome data that are 
missing at random. As an additional analysis, as recommended by the Data Monitoring 
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Committee, we used multiple imputation on a dataset with all baseline and outcome 
variables.  
The primary outcome (number of recorded offences with convictions) and time to first 
offence outcome were tested for subgroup effects, with the following moderators considered: 
age, sex, baseline diagnoses of conduct disorder, depression, anxiety or ADHD, early-onset 
conduct disorder, offences before the trial, referral path as categorical variables, and baseline 
callous-unemotional traits, antisocial beliefs and attitudes, and peer delinquency scores as 
continuous variables. 
A health economic evaluation was also carried out as part of the study. Unfortunately, due to 
an administrative error there was a large amount of missing data for the EQ-5D-5L measure. 
Consequently, we report the health economic methods and findings in the appendix (p. 37) 
Role of the funding source 
Representatives of the funders and MST-UK were invited to and were present at all Trial 
Steering Committee meetings but had no input into the design, data collection, analysis, or 
interpretation of the study findings. The corresponding author had full access to all the study 
data and had final responsibility for the decision to submit for publication. 
Results 
Patient flow is illustrated in Figure 1. In total, 684 young people were randomised, and 609 
(89%) were available for collecting the primary outcome measure at 60-month follow-up. 
Service use data were available for 607 (88·7%) of the participants, excluding only those who 
withdrew from the study. Attrition in relation to interview and self-report measures was 
greater, with 491 (77·9%), 478 (69·9%), 433 (63·3%), and 349 (51·0%) of participants 
contributing at 18, 24, 36, and 48 months, respectively. Excluding the 15% loss of 
participants for the 6-month visit, (19·4% attrition in MAU arm), the average loss of data was 
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approximately 7% between each 6-monthly visit to the 48-month point (1% per month). Loss 
to follow-up could not be predicted from baseline characteristics (appendix pp.4-6). 
For the primary outcome, there were no significant differences between interventions in the 
proportion of young people with a criminal offence with a conviction at 60-month follow-up: 
188 (55%) of 342 young people in the MST group had at least one criminal offence compared 
with 180 (53%) of 341 in the MAU group (odds ratio 1·13, 95% CI: 0·82, 1·56; p=0·44).  
There were no significant differences in median time to first offence, which was 36 months 
post-baseline for the MST group and 48 months for the MAU group (hazard ratio 1·03, 95% 
CI: 0·84, 1·26; p=0·78). Analyses of the number of recorded offences for both groups are 
shown in Table 2, and breakdown by violent and non-violent offences is provided in the 
appendix (p.18). Young people in the MST group had significantly (after adjustment) more 
recorded offences than those in the MAU group at 24 months (0·75 and 0·41, respectively; 
adjusted mean difference 0·35, 95% CI: 0·03, 0·67, p=0·031) and at 48 months (0·39 and 
0·39; adjusted mean difference 0·35, 95% CI: 0·00, 0·69; p=0·049). When violent and non-
violent offences were analysed separately, no significant difference between the groups was 
found at any timepoint. 
We report on secondary outcomes between 18 months and 48 months aggregated, and at 24, 
36, and 48 months. After correcting for multiple testing with the Benjamini–Hochberg 
method, no group differences were found on measures of antisocial behavioural problems 
(SDQ), callous-unemotional traits (ICU), conduct problems (SRD), antisocial beliefs and 
attitudes (ABAS), attention, hyperactivity, learning, or language problems (CBRS), 
behavioural and emotional problems (ABC and ASR), or the Materialism Scale. 
Parents in the MAU group reported higher levels of inconsistent discipline on the APQ 
compared with those in the MST group at 24-month follow-up (difference=–0·64, (95% CI –
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1·05 to –0·24; p=0·0023). Other measures of parenting skills, including family functioning 
(Loeber Caregiver Questionnaire), family adaptability (FACES-IV), expressed emotions 
(LEE), and family conflict (CTS2), did not identify any significant between-group 
differences. 
No between-group differences were observed on measures of wellbeing and adjustment 
(SMFQ), young people’s and parental wellbeing (SDQ), general psychiatric wellbeing 
(GHQ), quality of life (SF-36), or significant life events (CLES-A). 
No significant differences were found in the percentage of young people in employment or 
education by 48-month follow-up; 70% of participants in the MST group were in education 
or employment, compared with 82% of those in the MAU group (odds ratio 0·53; 95% CI: 
0·27, 1·03; p=0·062). There were no significant differences in the likelihood of participants 
in either group experiencing or causing pregnancy; the reported rates by 48-month follow-up 
were 17% in the MST group and 22% in the MAU group (odds ratio 0·72; 95% CI: 0·46, 
1·13; p=0·16). 
The results of prespecified interaction tests performed are given in the appendix (p.19). Only 
peer delinquency score had evidence of significantly moderating treatment outcome 
(Interaction OR per one-unit increase 0.91, CI 0.85 to 0.98, p=0.012): MST had significantly 
higher benefit as peer delinquency increased. There was a marginal moderation from sex, 
with female adolescents being slightly more likely to do better in the MST group compared 
with those in the MAU group. Contrary to expectation, none of the indicators of severity we 
measured (early onset of conduct disorder, high callous-unemotional behaviour, previous 
offences) provided a selective indication for MST.  
A similar pattern of results was observed for the analysis of data on time to first offence. 
Participants with higher baseline peer delinquency scores on the SRD were more likely to 
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have a delay in offending in the MST group compared with the MAU group, but this effect 
was reversed for those with lower baseline peer delinquency scores (p=0·015). Figure 2 
illustrates the proportion of non-offenders over the follow-up period who had high or low 
peer delinquency scores at baseline. Other prespecified moderators had no effect on the 
capacity of MST to delay time to first offence (appendix, p.19).  
Discussion 
In our previous study following participants up to 18 months post-randomisation, the START 
trial found no evidence of superiority of MST in reducing out-of-home placements or 
criminal offending, but in the same period there was parental and self-reported evidence of 
greater, and particularly more rapid, changes in antisocial behaviours and some superiority on 
measures of mood and wellbeing.9 The 5-year follow-up reported here found no significant 
difference in overall recorded offending rates with convictions in young people in the MST 
group compared with those in MAU. The analyses of mean offending at different timepoints, 
however, suggested that outcomes were somewhat better among those receiving standard 
intervention from regular services (ie, MAU), as at two timepoints the MAU group showed 
significantly lower rates of offending. It should be noted that the number of recorded offences 
was not large and was always less than one offence per participant. However, consistent with 
the higher number of recorded offences in the MST group, there was a tendency for more 
young people from the MAU group to be in education or employment. 
Analyses of key secondary outcomes did not indicate that MST was superior to MAU. The 
more rapid improvement in parent-rated antisocial behaviour observed within 1 year of the 
intervention9 was not generally sustained over 48-month follow-up. The data showed that 
MST was superior in continuing to reduce inconsistent discipline at 24 months, but there 
were no other indications of lasting benefit from MST on the measures associated with 
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antisocial behaviour and attitudes, parenting skills and family functioning, and young 
people’s and parental wellbeing and adjustment.  
These findings are not consistent with results from MST studies in the USA,6 which found 
that MST was superior to MAU on measures of criminal offending. There are key differences 
in the social context and study designs that might account for disparities between the long-
term effectiveness data from the USA and the UK. First, the criminal justice system in the 
USA has a stronger emphasis on punishment than that in the UK, where the emphasis is on 
rehabilitation.30 Participants in studies in the USA may have been more motivated to engage 
in MST if the other options open to them were less desirable.  
Because referrals were made by a variety of services rather than just coming from the 
criminal justice system, the START trial probably captured a group of young people with 
more diverse needs compared with previous studies of MST and may have comprised less 
severe cases than the bulk of trials in the USA. Importantly, the principles underpinning 
MAU services in England overlap with the evidence-based, social learning theory-inspired 
principles for parenting that underlie MST, making MAU in the UK more similar to the MST 
approach than MAU services in the USA might be. Further, effective systemic approaches for 
antisocial behaviour and criminality have been shown to have numerous common working 
elements.31 
Despite the contextual differences in relation to international comparisons, the findings of the 
trial may be generalisable to the UK population. The trial is the largest evaluation of the long-
term effects of MST to date. Families were recruited into the trial using carefully selected 
criteria to cater for the multi-agency approach the UK takes to young people with antisocial 
behaviour problems, and 87% of the eligible families agreed to take part. We were able to 
obtain offending and service use data on almost all participants who continued to consent to 
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data collection, and the proportion who actively wished to discontinue participation was 
relatively small (14%).  
To attempt to gain information on problems for which MST may be particularly helpful, we 
pre-planned a significant number of moderator analyses based on a range of indicators with 
the potential to identify distinct subgroups of young people with antisocial problems. The 
results of these analyses were disappointing. However, the results suggest that MST may be  
particularly helpful for young people with more delinquent peer social connections, who thus 
have more opportunity to engage in crime; higher numbers of deviant peers reported by 
participants were associated with elevation in virtually all symptoms of conduct disorder, 
including truancy, substance use, and perpetration of aggression. Our findings suggest that 
this group may specifically benefit from MST while those with fewer delinquent contacts are 
less well served by this approach. 
The study has several limitations. It was not possible to deliver on some aspects of the design, 
including incorporating data on school absence from the National Pupil Database (which we 
were unable to link to reliably), and there was substantial attrition by 48 months on secondary 
outcomes. The description of the characteristics of the services delivered to both arms of the 
trial across the 5-year follow-up period is partial, as most of the MST sites that took part in 
the trial had shut down by the 36-month follow-up point (when the evaluation was planned to 
be carried out) and the researchers could not contact the clinicians who had delivered the 
intervention. Furthermore, an administrative error resulted in gaps in the baseline EQ-5D-3L 
data. Efforts were made to impute the information, but it is possible that the measure was not 
sensitive enough to detect broader changes in these young people’s quality of life (see 
appendix p.46). It is possible that because services made proactive bids to participate in the 
trial, MAU interventions may have been of a higher standard than MAU services across the 
country on average, although we have no evidence to support such a claim. If this was indeed 
16 
the case then we can conclude only that MST shows no superiority over MAU delivered to a 
high standard. 
Although these limitations should be taken into account, the findings evidently do not suggest 
that MST is more beneficial than MAU in the long term for young people with antisocial 
behaviour problems. There is also no evidence to suggest that MST saves resources or that 
investment in MST is cost-effective. Treatment effects associated with MST and MAU 
appear stable and relatively invariant in their trajectory after 18 months. As MAU was 
delivered in the context of an RCT, we can assume that a relatively rigorous approach was 
taken in both arms of the intervention in this trial and to case management. While this may 
have contributed to our finding no significant benefit associated with MST, the findings 
suggest that unexpectedly good outcomes can be achieved in this clinical population which is 
generally considered to respond poorly to interventions when sufficient focused clinical effort 
is made.  
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RESEARCH IN CONTEXT 
 
Evidence before this study 
We did a systematic review to identify randomised controlled trials and systematic reviews of 
multisystemic therapy (MST) for adolescent antisocial behaviour for our previous report on 
the outcomes of this trial to 18 months. The review encompassed studies to Dec 31, 2016, 
and found 22 primary randomised trials of MST. Previous reviews (eg, for NICE) identified 
MST as a promising intervention for young people with conduct problems. However, the 
outcomes of the trials were mixed, with generally good outcomes in studies based in the 
USA, but some reports of non-USA studies suggesting that MST was no more effective at 
reducing antisocial behaviour than usual services. 
We did an additional search of Embase, MEDLINE and PsycINFO for any relevant 
randomised trials of MST that had been published from Jan 1, 2017 to Dec 1, 2019, using the 
terms “multisystemic therapy” or “MST”. We found one additional trial published in 2018. In 
total, 13 studies were carried out in the USA and 10 in Europe. The median follow-up period 
was 18 months, ranging from 6 months to 22 years. With the exception of two USA-based 
studies that followed up a 1995 trial of MST 13 and 22 years later, no trial evaluated MST 
outcomes for more than 48 months. 
We have previously published the outcomes of the START trial to 18 months. At the time, it 
was the only independent large-sample trial evaluating the medium-term superiority and cost-
effectiveness of MST in the UK. We found no additional benefit of MST compared with 
management as usual in terms of out-of-home placements, but MST did have a positive effect 
for parent-reported offending behaviour at 18 months and was associated with a faster rate of 
positive behavioural changes.  
22 
 
Added value of this study 
The present study follows on from the initial 18-month follow up, reporting criminal 
convictions to 60 months post-baseline and secondary (self-reported) outcomes, including an 
economic analysis, to 48 months. Most evaluations of the effectiveness of MST from the 
USA to date have indicated that it is more effective than other interventions. Evidence from 
European countries has been more equivocal. To our knowledge, this is the longest follow-up 
for a randomised controlled evaluation of MST in the UK to date.  The outcomes do not 
support the long-term superiority of MST, despite the results of the initial 18-month follow-
up where parents report suggested more rapid change associated with MST. These outcomes 
include the proportion of young people who offended at 60-month follow-up and secondary 
evaluations of young people’s behaviour and adjustment, psychosocial functioning, family 
functioning, and quality of life, as well as the cost-effectiveness of MST compared with 
management as usual.  
 
Implications of all the available evidence 
Our results do not support the superiority of MST in the UK for young people with conduct 
problems, and we found no evidence of MST being more cost-effective in the long term. It is 
possible that MST is more beneficial in the context of the social services and criminal justice 
system in the USA, but that in the UK the needs of young people with conduct problems are 




Demographic characteristics at baseline 
 MST (N=342) MAU (N=342) 
Age (years) 13.7 (1.4) 13.9 (1.4) 
Sex   
     Female 126 (37%) 124 (36%) 
     Male 216 (63%) 218 (64%) 
Socioeconomic status (range 1-6) 3.0 (1.4) 2.9 (1.3) 
Proportion on state benefits or earning <£20,000 
each year 
258 (75%) 267 (78%) 
Ethnicity   
     White British/European  261 (76%) 274 (80%) 
     Black African/Afro-Caribbean  38 (11%) 33 (10%) 
     Asian  6 (2%) 10 (3%) 
     Mixed/Other 34 (10%) 17 (5%) 
Parents’ marital status   
     Single or widowed  142 (42%) 131 (38%) 
     Separated or divorced  77 (23%) 59 (17%) 
     Married or cohabiting 123 (36%) 147 (43%) 
Number of siblings 2.5 (1.3) 2.5 (1.4) 
Siblings offending 118 (35%) 126 (37%) 
Offences in the year before referral   
     Non-offender on referral 124 (36%) 111 (32%) 
     Total number of offences 1.1 (2.2) 1.2 (2.5) 
     Violent offences 0.4 (1.0) 0.4 (0.9) 
     Non-violent offences 0.5 (1.2) 0.6 (1.3) 







Mean number of offences by treatment group and summary of effect of multisystemic 
therapy, in 12-month intervals 
Time MST MAU Difference p.value 
1-12 months 1.07 1.26 -0.07 (-0.39,0.24) 0.650 
13-24 months 0.75 0.41 0.35 (0.03,0.67) 0.031 
25-36 months 0.45 0.37 0.33 (-0.02,0.67) 0.063 
37-48 months 0.39 0.39 0.35 (0,0.69) 0.049 
49-60 months 0.3 0.28 -0.08 (-0.46,0.31) 0.700 










Figure 2. (a) Proportion of non-offenders by treatment group. (b) Proportion of non-
offenders by treatment group and baseline peer delinquency (PD) score, dichotomised 




Figure 3. Bootstrapped mean differences in costs and effects (QALYs) of MST 
compared with MAU at 48-month follow-up 
 
 
